INTELLIPHARMACEUTICS INTL IN's ticker is IPCI and the CUSIP is 458173101. A total of 25 filers reported holding INTELLIPHARMACEUTICS INTL IN in Q1 2018. The put-call ratio across all filers is 2.80 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $0 | – | 100 | 0.0% | 0.00% | – |
| Q1 2018 | $0 | – | 100 | -80.0% | 0.00% | – |
| Q4 2017 | $0 | – | 500 | +150.0% | 0.00% | – |
| Q3 2017 | $0 | -100.0% | 200 | -80.0% | 0.00% | – |
| Q2 2017 | $3,000 | +200.0% | 1,000 | +233.3% | 0.00% | – |
| Q1 2017 | $1,000 | 0.0% | 300 | +50.0% | 0.00% | – |
| Q4 2016 | $1,000 | 0.0% | 200 | -71.1% | 0.00% | – |
| Q1 2016 | $1,000 | -50.0% | 692 | -42.7% | 0.00% | – |
| Q4 2015 | $2,000 | +100.0% | 1,208 | +202.0% | 0.00% | – |
| Q3 2015 | $1,000 | -90.9% | 400 | -88.8% | 0.00% | -100.0% |
| Q2 2015 | $11,000 | -80.0% | 3,580 | -81.8% | 0.00% | -85.7% |
| Q1 2015 | $55,000 | +37.5% | 19,637 | +10.9% | 0.01% | +75.0% |
| Q4 2014 | $40,000 | 0.0% | 17,703 | +33.2% | 0.00% | 0.0% |
| Q3 2014 | $40,000 | +14.3% | 13,287 | +41.4% | 0.00% | 0.0% |
| Q2 2014 | $35,000 | +337.5% | 9,396 | +457.6% | 0.00% | +300.0% |
| Q1 2014 | $8,000 | +166.7% | 1,685 | +108.0% | 0.00% | 0.0% |
| Q4 2013 | $3,000 | – | 810 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atria Investments, Inc | 75,895 | $159,000 | 0.02% |
| FIRST FOUNDATION ADVISORS | 100,900 | $212,000 | 0.02% |
| Argent Trust Co | 15,121 | $32,000 | 0.01% |
| Acrospire Investment Management LLC | 1,500 | $3,000 | 0.00% |
| Virtu KCG Holdings LLC | 33,485 | $70,000 | 0.00% |
| SIMPLEX TRADING, LLC | 9,846 | $20,000 | 0.00% |
| Advisor Group, Inc. | 11,791 | $25,000 | 0.00% |
| Hudson Bay Capital Management LP | 10,000 | $21,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 6 | $0 | 0.00% |
| WELLS FARGO & COMPANY/MN | 1,038 | $2,000 | 0.00% |